Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-118543
Filing Date
2016-05-09
Accepted
2016-05-09 17:41:07
Documents
1
Period of Report
2016-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4004
  Complete submission text file 0001209191-16-118543.txt   5273
Mailing Address
Business Address
DORSA CAROLINE (Reporting) CIK: 0001181174 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 161632957

Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances